Document is current
Any future updates will be listed below
-
Authors
Nakashima, Ryosuke
Ikeda, Shota
Shinohara, Keisuke
Matsumoto, Sho
Yoshida, Daisuke
Ono, Yoshiyasu
Nakashima, Hiroka
Miyamoto, Ryohei
Matsushima, Shouji
Kishimoto, Junji
Itoh, Hiroshi
Komuro, Issei
Tsutsui, Hiroyuki
Abe, Kohtaro
- License Information
-
More Information
Article History
Received: 16 November 2024
Accepted: 4 March 2025
First Online: 17 March 2025
Declarations
:
: K.S. reports grants from Daiichi Sankyo, Nippon Boehringer Ingelheim, and Otsuka Medical Devices. H.I. reports personal fees from SBI Pharmaceuticals, Wakunaga Pharmaceutical, NIPRO, Meiji, Taisho Pharmaceutical, Ono Pharmaceutical, Kowa, Takeda Pharmaceutical, Daiichi Sankyo, and Novartis Pharma. I.K. reports grant and/or personal fees from Idorsia Pharmaceuticals Japan, Daiichi Sankyo, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma, Teijin Pharma, AstraZeneca, Kowa, MSD, Otsuka Pharmaceutical, Ono Pharmaceutical, Nippon Boehringer Ingelheim, Novartis Pharma, and Bayer Yakuhin. H.T. reports grants and/or personal fees from Daiichi Sankyo, Novartis Pharma, Otsuka Pharmaceutical, Pfizer Japan, Mitsubishi Tanabe Pharma, Teijin Pharma, Nippon Boehringer Ingelheim, AstraZeneca, Ono Pharmaceutical, Kowa, IQVIA Service Japan, MEDINET, Medical Innovation Kyushu, Bayer Yakuhin, Johnson & Johnson, NEC, Nippon Rinsho and Japanese Heart Failure Society. K.A. received grants from Mochida Pharmaceutical and Actelion Pharmaceuticals Japan. Other authors report no conflicts of interest.
